- Home
- /
- Treatment
- /
- Page 81
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Everolimus | Stomach Cancer | Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936 | May 24, 2011 | |
Camostat | Chronic Pancreatitis | NIXS Corporation;Nichi-Iko Pharmaceutical Co., Ltd., 7th Floor - NOF Nihonbashi Honcho Bldg;Tokyo | May 18, 2011 | |
Adalimumab | Ulcerative colitis | AbbVie, Inc.;1 N. Waukegan Road;North Chicago, Illinois, 60064 | May 11, 2011 | |
Acadesine | Multiple myeloma | Advancell-Advanced In Vitro Cell Technologies S.A.;Via Augusta 59, 3rd floor, door 313;Barcelona | May 4, 2011 | |
Humanized monoclonal antibody to TumorEndothelial Marker-1 | Soft tissue sarcoma | Morphotek;210 Welsh Pool Rd;Exton, Pennsylvania, 19341 | April 29, 2011 | |
Ferumoxytol | For use in MR imaging for the mangement of brain tumors | Edward A. Neuwelt, MD;Oregon Health & Science University, 3181 SW Sam Jackson Park Road - Mail Code L603;Portland, Oregon, 97239 | April 29, 2011 | |
Clarithromycin, rifabutin, clofazimine | Pediatric Crohn's disease | RedHill Biopharma Ltd.;42 Givati St.; | April 26, 2011 | |
Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-Ã?ÂÃÃ?Ã?Â&Ã?ýÃ?ÂÃÃ?ÂÃ?ñ-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[ | Prevention of ischemia reperfusion injury associated wth solid organ transplantation | Endotis Pharma;102, avenue Gaston Roussel; | April 18, 2011 | |
Tissue Plasminogen activator | Acute ischemic stroke (AIS) in children age 16 years and younger | Catherine Amlie-Lefond, MD;University of Washington, 4800 Sand Point Way NE - M/S B5552;Seattle, Washington, 98105 | April 18, 2011 | |
4,5,6,7-tetrachloro-2′,4′,5′,7′-tetraiodofluorescein disodium salt | Hepatocellular Carcinoma | Provectus Pharmaceuticals, Inc.;7327 Oak Ridge Highway;Knoxville, Tennessee, 37931 | April 18, 2011 | |
Recombinant humanized anti-LOXL2 monoclonal antibody | Idiopathic pulmonary fibrosis | Gilead Sciences, Inc.;199 East Blaine St.;Seattle, Washington, 98102 | April 18, 2011 | |
DNA plasmid encoding the acetylcholine receptor | Myasthenia gravis Myasthenia gravis | Bayhill Therapeutics;1804 Embarcadero Rd., Suite 201;Palo Alto, California, 94303 | April 18, 2011 | |
Etirinotecan pegol | Ovarian cancer | Nektar Therapeutics;455 Mission Bay Blvd, South;San Francisco, California, 94158 | April 18, 2011 | |
DOXO-EMCH | Adenocarcinoma of the pancreas | NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 | April 18, 2011 | |
Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-�?���?�?�&�?�½�?���?��?�±-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[ | Prevention of ischemia reperfusion injury associated wth solid organ transplantation | Endotis Pharma;102, avenue Gaston Roussel; | April 18, 2011 | |
Heptadecasodium salt of an 18-base residue phosphorothioate oligonucleotide | Spinal muscular atrophy | Isis Pharmaceuticals, Inc.;1896 Rutherford Road;Carlsbad, CA, 92008 | April 18, 2011 | |
Abeotaxane inhibitor of microtubules | Pediatric neuroblastoma | Cortice Biosciences;1345 Avenue of the Americas, 42nd Floor;New York, New York, 10105 | April 18, 2011 | |
Nusinersen | Spinal muscular atrophy | Biogen, Inc;225 Binney Street;Cambridge, Massachusetts, 02142 | April 18, 2011 | |
5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine hydrochloride | Progressive supranuclear palsy | Mithridion, Inc.;505 Science Drive;Madison, Wisconsin, 53711 | April 18, 2011 | |
Bi-shRNAfurin and granulocyte macrophage colony stimulating factor augmented autologus tumor cell vaccine | Ovarian cancer | Gradalis, Inc.;2545 Golden Bear Drive;Carrollton, Texas, 75006 | April 18, 2011 | |
Firtecan pegol | Neuroblastoma | Enzon Pharmaceuticals, Inc.;20 Kingsbridge Road;Piscataway, New Jersey, 08854 | April 18, 2011 | |
(R)-1-phenylethyl-5-(4-biphenyl-4-cyclopropanecarboxylic acid)-3-methylisoxazole-4-yl carbamate sodium salt | Idiopathic pulmonary fibrosis | Bristol-Myers Squibb Company;P. O. Box 4000;Princeton, New Jersey, 08543 | April 15, 2011 | |
Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA | Amyloidosis | Alnylam UK Limited | April 15, 2011 | |
Selective deacylglycerol acyltransferase 1 inhibitor | Hypertriglyceridemia in te setting of Type I hyperlipoproteinemia, also known as Familial Chylomicronemia Syndrome | Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936 | March 28, 2011 | |
Acetyl-l-carnitine (ALC) | Rett syndrome | Leadiant Biosciences, Inc.;9841 Washingtonian Blvd., Suite 500;Gaithersburg, Maryland, 20878 | March 18, 2011 |